IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 138 filers reported holding IMMUNOCORE HLDGS PLC in Q4 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $730,329 | +985.6% | 21,550 | +1982.1% | 0.01% | +500.0% |
| Q1 2024 | $67,275 | +216.6% | 1,035 | +232.8% | 0.00% | – |
| Q4 2023 | $21,248 | -87.9% | 311 | -90.8% | 0.00% | -100.0% |
| Q3 2023 | $175,837 | +14.2% | 3,388 | +31.9% | 0.01% | +20.0% |
| Q2 2023 | $153,977 | +48626.9% | 2,568 | -59.8% | 0.01% | -50.0% |
| Q1 2023 | $316 | +146.9% | 6,388 | +185.1% | 0.01% | +100.0% |
| Q4 2022 | $128 | -99.9% | 2,241 | -28.7% | 0.01% | +150.0% |
| Q3 2022 | $148,000 | +1245.5% | 3,145 | +1003.5% | 0.00% | – |
| Q2 2022 | $11,000 | +1000.0% | 285 | +1400.0% | 0.00% | – |
| Q4 2021 | $1,000 | – | 19 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $34,592,303 | 27.53% |
| RTW INVESTMENTS, LP | 6,029,633 | $361,536,795 | 6.88% |
| Paradigm Biocapital Advisors LP | 1,270,124 | $76,156,635 | 5.88% |
| Rock Springs Capital Management LP | 3,028,410 | $181,583,464 | 4.32% |
| Logos Global Management LP | 500,000 | $29,980,000 | 4.08% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $24,319,776 | 3.58% |
| GREAT POINT PARTNERS LLC | 297,082 | $17,813,037 | 3.49% |
| Eschler Asset Management LLP | 34,000 | $2,038,640 | 2.89% |
| COWEN AND COMPANY, LLC | 460,036 | $27,583,758 | 2.29% |
| HighVista Strategies LLC | 44,094 | $2,643,876 | 1.21% |